NeuroKaire
Tel Aviv-yafo
About NeuroKaire
NeuoKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.0M
- Last round: Series Unknown (Dec 2024)
- Website: neurokaire.com
Industries & Categories
Health Care, Personal Health, Psychology
Social Profiles
Canonical: https://fsome.com/organization/neurokaire-65315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.